A study for a 54 year old woman who takes Letrozole, Cymbalta - from FDA reports


108 females aged 54 (±5) who take the same drugs are studied. This is a personalized study for a 54 year old female patient who has Breast Cancer, Neuropathy - Peripheral. The study is created by eHealthMe based on reports from FDA.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials). If you find eHealthMe useful, please help us to spread the words below or leave us a testimonial.



On Dec, 06, 2018

108 females aged 54 (±5) who take Letrozole, Cymbalta are studied.


Number of reports submitted per year:

Letrozole, Cymbalta for a 54-year old woman.

Information of the patient in this study:

  • Age: 54
  • Gender: female
  • Conditions: Breast Cancer, Neuropathy - Peripheral
  • Drugs taken:
    • Letrozole (letrozole)
    • Cymbalta (duloxetine hydrochloride)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
  1. Fever
  2. Urinary tract infection
  3. Joint pain
  4. Post-traumatic stress disorder
  5. Respiratory tract congestion (blockage on respiratory system)
1 - 6 months:
  1. Weight decreased
  2. Breathing difficulty
  3. Fatigue (feeling of tiredness)
  4. General physical health deterioration (weak health status)
  5. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
6 - 12 months:
  1. Weight decreased
  2. Breathing difficulty
  3. Fatigue (feeling of tiredness)
  4. General physical health deterioration (weak health status)
  5. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
1 - 2 years:
n/a
2 - 5 years:
  1. Intervertebral disc degeneration (spinal disc degeneration)
  2. Compression fracture (fracture due to pressure caused by injury)
  3. Tricuspid valve incompetence (inefficient heart valve)
  4. Gliosis (a process leading to scars in the central nervous system)
  5. Upper respiratory tract infection
5 - 10 years:
n/a
10+ years:
n/a
not specified:
  1. Pain
  2. Fall
  3. Nausea (feeling of having an urge to vomit)
  4. Osteonecrosis of jaw (death of bone of jaw)
  5. Nausea and vomiting

Top conditions involved for these people *:

  1. Metastases To Bone (cancer spreads to bone): 34 people, 31.48%
  2. Pain : 25 people, 23.15%
  3. Multiple Myeloma (cancer of the plasma cells): 15 people, 13.89%
  4. Oedema (fluid collection in tissue): 13 people, 12.04%
  5. Metastasis (spreadable cancer to other organ from origin): 13 people, 12.04%

Top co-used drugs for these people *:

  1. Zometa (54 people, 50.00%)
  2. Aredia (42 people, 38.89%)
  3. Faslodex (38 people, 35.19%)
  4. Xanax (32 people, 29.63%)
  5. Ambien (31 people, 28.70%)

* Some reports may have incomplete information.

FDA reports used in this study

You are not alone:

What are the drugs?

What are the conditions?



Related studies:

Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!